USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ADVAITA CORPORATION
Address:
8703 Brookville Rd.
Plymouth, MI
Phone:
N/A
URL:
N/A
EIN:
120266944
DUNS:
198047529
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $148,487.00 1
STTR Phase I $146,256.00 1
STTR Phase II $2,229,094.00 1

Award List:

A Novel Method for Signaling Pathway Analysis

Award Year / Program / Phase:
2009 / STTR / Phase I
Award Amount:
$146,256.00
Agency:
HHS
Principal Investigator:
Sorin Draghici
Research Institution:
WAYNE STATE UNIVERSITY
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): A common challenge in the analysis of genomics data is trying to understand the underlying phenomenon in the context of all complex interactions on various regulatory pathways. Currently, a statistical approach is unive rsally used to identify the most relevant… More

Pathway-Guide: A novel tool for the analysis of signaling and metabolic pathways

Award Year / Program / Phase:
2011 / STTR / Phase II
Award Amount:
$2,229,094.00
Agency:
HHS
Principal Investigator:
Sorin Draghici – 313-577-5484
Research Institution:
WAYNE STATE UNIVERSITY
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Once heralded as the Holy Grail, the capability of obtaining a comprehensive list of genes, proteins or metabolites that are different between disease and normal is routine today. And yet, the holy grail of high-throughput has not delivered so far. Even though… More

Increasing the efficacy of MTI-101 in MM using Ab conjugation strategies

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$148,487.00
Agency:
HHS
Principal Investigator:
John R. Hartman – 313-426-9050
Abstract:
DESCRIPTION (provided by applicant): Once heralded as the holy grail, the capability of obtaining a comprehensive list of genes, proteins or metabolites that are different between disease and normal is routine today. And yet, the holy grail of high-throughput has not delivered so far. Even though… More